US drug approvals
15 approvals with a product on the US market
- Bosulif NDA217729 · approved 26 Sep 2023
- Xalkori NDA217581 · approved 7 Sep 2023
- Xeljanz NDA203214 · approved 6 Nov 2012
- Bosulif NDA203341 · approved 4 Sep 2012
- Inlyta NDA202324 · approved 27 Jan 2012
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.